AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glinix MF 80mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Saphnix Life Sciences

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glinix MF 80mg/500mg Tablet SR

Diabexe Duo 80mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo 80mg/500mg ER Tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential to manage hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating women should seek medical advice. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be necessary.

Primary Ingredients of Glinix MF 80mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Glinix MF 80mg/500mg Tablet SR

Non-insulin-dependent diabetes

Major Benefits of Glinix MF 80mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Glinix MF 80mg/500mg SR tablet should be taken with a meal.

Common Side effects of Glinix MF 80mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glinix MF 80mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and length of treatment for this medication. Ingest the Glinix MF 80mg/500mg Tablet SR whole; do not chew, crush, or divide it. Administer this medication with food.

How Glinix MF 80mg/500mg Tablet SR works:

Gliclazide and metformin, combined as Glinix MF 80mg/500mg sustained-release tablets, offer a dual approach to diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glinix MF 80mg/500mg Tablet SR with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glinix MF 80mg/500mg tablets are contraindicated during pregnancy due to confirmed fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glinix MF 80mg/500mg tablet is likely unsafe for breastfeeding mothers. Preliminary human studies indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use the extended-release Glinix MF 80mg/500mg tablet cautiously, as dosage modification may be necessary. Consult your physician. Glinix MF 80mg/500mg tablet extended-release is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

The extended-release Glinix MF 80mg/500mg tablet requires careful administration in individuals with hepatic impairment. Dosage modification of Glinix MF 80mg/500mg Tablet SR may be necessary. Physician consultation is advised. Initiation of Glinix MF 80mg/500mg Tablet SR therapy typically begins with a reduced dose for patients exhibiting mild to moderate liver dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glinix MF 80mg/500mg Tablet SR :

Should you forget a dose of Glinix MF 80mg/500mg SR tablets, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glinix MF 80mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glinix MF 80mg/500mg Tablet SR

Glinix MF 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glinix MF 80mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glinix MF 80mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Glinix MF 80mg/500mg Tablet SR can cause lactic acidosis, a serious, potentially life-threatening condition (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glinix MF 80mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Glinix MF 80mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glinix MF 80mg/500mg SR Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Their use is also contraindicated in individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glinix MF 80mg/500mg Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
Glinix MF 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 DM.
Glinix MF 80mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glinix MF 80mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glinix MF 80mg/500mg Tablet SR can cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a serious medical emergency characterized by high blood lactic acid levels. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glinix MF 80mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Glinix MF 80mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with external vitamin B12 sources is recommended by some researchers.
Glinix MF 80mg/500mg Tablet SR is contraindicated in patients allergic to its components or excipients, and those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Glinix MF 80mg/500mg SR tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glinix MF 80mg/500mg Tabl...
70
MRP 81
13% off